InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
T+90 hit rate
50%
T+90 mean return
-5.9%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Watkin Jared, Chief Executive Officer. Officer active across 1 company, notably Abbott Laboratories. In total, 6 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €1.9m. History available since 30 April 2021. The latest transaction was disclosed on 28 February 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
5,598 shares@ US$99.7716.7% of flowCommon shares without par valueSEC:0001415889-23-003922:0
11,617 shares0Common shares without par valueSEC:0001415889-23-003072:0
6,759 shares@ US$122.410.0003% mcap28.2% of flowCommon shares without par valueSEC:0001415889-22-002203:0
14,559 shares0Common shares without par valueSEC:0001415889-22-001748:0
9,533 shares@ US$120.01635.9% of flowCommon shares without par valueSEC:0001415889-21-002268
9,533 shares@ US$120.0160.0004% mcap35.9% of flowCommon shares without par valueSEC:0001415889-21-002268:0
6 of 6 declarations
About Watkin Jared
Jared Watkin serves as Chief Executive Officer and Senior Vice President at ABBOTT LABORATORIES. He is responsible for the strategic direction of the company and managing operations. His role is essential in ensuring that the company meets its growth and innovation objectives.
